Daxor (DXR) News Today $9.03 +0.04 (+0.44%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartFinancialsHeadlinesSEC Filings All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period DAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24October 9, 2024 | finance.yahoo.comNewly Published Review Highlights the Pivotal Role of Daxor's Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome ManagementSeptember 12, 2024 | stockhouse.comDaxor Corporation Receives $300K Matching Fund Award From Launch TennesseeSeptember 5, 2024 | finance.yahoo.comLeading Central Florida Hospital Implements Daxor’s BVA-100™ Blood Volume Diagnostic for Heart Failure Patient CareSeptember 4, 2024 | finance.yahoo.comDaxor Corporation Awarded New U.S. Defense Health Agency Contract for Added Capabilities to Its Point-of-Care Blood Volume AnalyzerJuly 24, 2024 | finance.yahoo.comDaxor Corporation (DXR) Stock Price, News, Quote & History - Yahoo FinanceMay 23, 2024 | finance.yahoo.comNew Studies Prove the Clinical Benefits of Daxor’s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of CongestionApril 16, 2024 | finance.yahoo.comDAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE SPRING’24 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100™)April 15, 2024 | finance.yahoo.comDaxor Corporation to Exhibit at the American College of Cardiology for ACC.24April 1, 2024 | finance.yahoo.comDaxor CFO Michel Robert J buys $6.5k in company stockMarch 29, 2024 | investing.comDestiny Tech100 IncMarch 28, 2024 | money.usnews.comDaxor Corporation (NASDAQ:DXR) Q4 2023 Earnings Call TranscriptMarch 28, 2024 | finance.yahoo.comDaxor Corp.March 23, 2024 | wsj.comDaxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024March 22, 2024 | finance.yahoo.comMulti-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor’s Unique Clinical Utility for Heart Failure PatientsMarch 8, 2024 | finance.yahoo.comDaxor Corporation Starts 2024 with Ongoing Growth in New Blood Volume Analyzer AcquisitionsFebruary 12, 2024 | finance.yahoo.comDaxor Stock (NASDAQ:DXR) Insider TradesFebruary 9, 2024 | benzinga.comDaxor Corporation Closes Q4 2023 with Growth in New Sales to Hospital Systems and Increased Utilization of its BVA-100® Blood Volume Diagnostic Across the U.S. at Existing AccountsFebruary 7, 2024 | finance.yahoo.comDaxor Corporation to Exhibit at the Society of Nuclear Medicine and Molecular Imaging Mid-Winter and American College Nuclear Medicine Annual MeetingJanuary 29, 2024 | finance.yahoo.comDaxor Corporation to Exhibit at the Society for Critical Care Medicine 2024 Critical Care CongressJanuary 16, 2024 | finance.yahoo.comDAXOR AWARDED ADDITIONAL NEW PATENT FOR SMART BLOOD VOLUME GUIDANCE TECHNOLOGY TO IMPROVE TREATMENT AND OUTCOMESJanuary 9, 2024 | finance.yahoo.comDaxor seeks US FDA approval for blood volume analyserJanuary 3, 2024 | msn.comDaxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume AnalyzerJanuary 2, 2024 | finance.yahoo.comAspira Women’s Health GAAP EPS of -$0.48 beats by $0.03, revenue of $2.22M misses by $0.68MNovember 13, 2023 | seekingalpha.comDaxor Corporation: New Randomized Controlled Trial Demonstrates the Efficacy of Daxor's BVA Guided-Care in Heart Failure PatientsNovember 13, 2023 | finanznachrichten.deNew Randomized Controlled Trial Demonstrates the Efficacy of Daxor’s BVA Guided-Care in Heart Failure PatientsNovember 13, 2023 | finance.yahoo.comDaxor Corporation Awarded New Patent for Remote Monitoring of Blood VolumeNovember 9, 2023 | finance.yahoo.comNeuronetics GAAP EPS of -$0.33 misses by $0.02, revenue of $17.9M beats by $0.32MNovember 7, 2023 | msn.comChief Financial Officer at Daxor Acquires Company Stock Options Worth 5,000 SharesNovember 5, 2023 | benzinga.comExpert Panelists Advocate Use of Daxor’s Technology to Optimize Treatment at Heart Failure Society of America Annual Scientific MeetingOctober 13, 2023 | finance.yahoo.comNew Data from Banner University Medicine Demonstrating Effectiveness of BVA-100® Use in Ambulatory Heart Failure Patients Presented at Heart Failure Society of America Annual Scientific MeetingOctober 11, 2023 | finance.yahoo.comDaxor Corporation Awarded Support from the National Institutes of Health (NIH) Catalyze Preclinical Services ProgramOctober 4, 2023 | finance.yahoo.comDaxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2023September 27, 2023 | finance.yahoo.comDAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE FALL’23 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100®)September 26, 2023 | finance.yahoo.comMaxim Group Keeps Their Buy Rating on Daxor (DXR)September 13, 2023 | markets.businessinsider.comDaxor Corporation Awarded $305K Grant from the National Institutes of Health to Develop Blood Volume Guidance Software in Sepsis PatientsSeptember 11, 2023 | finance.yahoo.comDaxor Corporation to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceSeptember 7, 2023 | finance.yahoo.comDaxor's Diagnostics Test Kits Revenue Climbs in 1HAugust 28, 2023 | marketwatch.comJACC-HF Reports Successful Heart Failure Trial With Daxor BVA-100®August 10, 2023 | finance.yahoo.comJACC-HF Study Compares Daxor’s BVA-100® Volume Metric to CardioMEMS® Pressure Metric in Heart Failure PatientsJuly 12, 2023 | finance.yahoo.comDaxor Corporation Announces Further Acquisitions and Increased Utilization of its BVA-100® Blood Volume Diagnostic Throughout the U.S.July 11, 2023 | finance.yahoo.comDaxor Corporation Awarded $1.1 Million Contract from the United States Defense Health Agency for Added Capabilities to its Point-of-Care Blood Volume AnalyzerJuly 5, 2023 | finance.yahoo.comDaxor Corporation Announces Partial Exercise of Over-Allotment Option in Secondary OfferingJune 22, 2023 | finance.yahoo.comDaxor Corporation to Showcase the Benefits of BVA-100® Guided Care at the American Association of Heart Failure Nurses (AAHFN) 19th Annual MeetingJune 20, 2023 | finance.yahoo.comDaxor Accelerates Blood Volume Analysis Adoption with the Launch of ezBVA Lab ServicesJune 15, 2023 | finance.yahoo.comDaxor Corporation to Participate in the Maxim Group Virtual Healthcare ConferenceJune 12, 2023 | finance.yahoo.comDaxor Corporation Announces Closing of $4.0 Million Underwritten Public OfferingMay 25, 2023 | finance.yahoo.comWhy Immix Biopharma Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving PremarketMay 22, 2023 | msn.comDaxor Nosedives on Stock OfferingMay 22, 2023 | msn.comDaxor shares tumble after pricing stock offering at discountMay 22, 2023 | seekingalpha.com Get Daxor News Delivered to You Automatically Sign up to receive the latest news and ratings for DXR and its competitors with MarketBeat's FREE daily newsletter. Email Address Tesla Execs are Freaking Out (Ad)It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss. Click here to get the details. DXR Media Mentions By Week DXR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DXR News Sentiment▼0.000.46▲Average Medical News Sentiment DXR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DXR Articles This Week▼00▲DXR Articles Average Week Get Daxor News Delivered to You Automatically Sign up to receive the latest news and ratings for DXR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BrainsWay News Today Alpha Tau Medical News Today Lakeland Industries News Today Nevro News Today KORU Medical Systems News Today Myomo News Today Pro-Dex News Today Sensus Healthcare News Today TriSalus Life Sciences News Today TELA Bio News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:DXR) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daxor Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Daxor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
